What Vir Biotechnology (VIR)'s profit swing but earnings miss means for shareholders Simply Wall St 2d
Fibrobiologics granted European patent covering Gene Therapy for the regeneration of cartilage PR Newswire (Press Release) 5d
Forlong biotechnology announces approval to initiate Phase I clinical trial of FL115 (il-15 superagonist) subcutaneous injection in Australia Business Wire (Press Release) 6d
1Elevan Biopharmaceuticals is building the infrastructure to be the partner of choice for peptide medicine PR Newswire (Press Release) 5d